<?xml version="1.0" encoding="UTF-8"?>
<p>Influenza A virus (IAV) poses a substantial threat to human health in the forms of seasonal epidemics and occasional pandemics (
 <xref rid="B27" ref-type="bibr">Reperant et al., 2014</xref>). IAV mainly targets the epithelial cells of the respiratory tract, but can also infect macrophages and dendritic cells (
 <xref rid="B34" ref-type="bibr">Veckman et al., 2006</xref>). The innate immune system initiates host defenses against IAV infection, which is triggered by pattern recognition receptors (PRRs) that recognize viruses or their genetic material (
 <xref rid="B21" ref-type="bibr">Kawai and Akira, 2006</xref>; 
 <xref rid="B38" ref-type="bibr">Wilkins and Gale, 2010</xref>). This recognition results in appropriate antiviral responses, including the production of a variety of cytokines and the induction of inflammatory and adaptive immune responses (
 <xref rid="B43" ref-type="bibr">Yoneyama and Fujita, 2010</xref>).
</p>
